Clinical Trials Browser

Phase 1 × Panobinostat × Thoracic × Clear all

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00535951 2020-12-19

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Phase 1 Completed

18 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma

NCT01336842 2018-01-09

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

Phase 1 Completed

23 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00958022 2017-06-22

Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer

Phase 1 Terminated

7 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Phase 1 Completed

38 enrolled

GenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

NCT00907179 2015-07-22

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Terminated

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00738751 2015-02-04

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Phase 1 Completed

44 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT01160731 2014-12-31

Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1 Withdrawn

Thoracic

Lung Neoplasms

Clinical Trials

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer